Related Experiment Video
Updated: May 28, 2025

11:16
Preparation and Gene Modification of Nonhuman Primate Hematopoietic Stem and Progenitor Cells
Published on: February 15, 2019
7.6K
Complement Activation and Hemolysis in Non-human Primates Following Transfusion of Genetically Modified Pig Red Blood
Hee Jung Kang1, Juhye Roh1, Haneulnari Lee1
1Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea.
Annals of Laboratory Medicine
|February 11, 2025
Summary
Transfusing pig red blood cells (RBCs) into nonhuman primates (NHPs) triggers immune responses. Complement activation levels correlate with RBC survival, offering insights into xenotransfusion compatibility.
Area of Science:
- Immunology
- Transfusion Medicine
- Xenotransplantation
Background:
- Pig red blood cells (RBCs) are rapidly eliminated in nonhuman primates (NHPs) due to immune reactions.
- Antibody binding and complement activation are key mechanisms in this immune response.
Purpose of the Study:
- To assess the relationship between post-transfusion hemolysis and complement activation.
- To investigate the impact of genetic modifications in pig RBCs on complement activation.
Main Methods:
- Transfusions of wild-type (WT), triple knockout (TKO), and genetically modified TKO pig RBCs into NHPs.
- Measurement of hemoglobin (Hb) levels, complement fragments (C3a, C4a, factor Bb), and agglutination titers post-transfusion.
- Comparison with NHP RBC transfusions and saline infusion.
Main Results:
- Transfusions restored Hb levels, unlike saline infusion.
- Xenotransfusions, particularly repeated xenotransfusions (ReXTf), showed significant increases in C3a and factor Bb.
- Complement activation levels correlated negatively with post-transfusion day 1 Hb levels.
- Genetic modification (TKO/hCD55.hCD39) delayed peak complement activation compared to TKO RBCs.
Conclusions:
- Post-transfusion complement activation is influenced by prior sensitization and genetic modifications of pig RBCs.
- Monitoring complement activation provides insights into the survival and compatibility of transfused RBCs in NHPs.
Keywords:
Agglutination titerAllotransfusionComplement activationFactor BbNon-human primatesPigRed blood cellsXenotransfusionMore Related Videos
Related Concept Videos
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion
470
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
470
Rh Blood Group
1.3K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.3K

